Literature DB >> 20129964

Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification.

F Damond1, V Avettand-Fenoel, G Collin, B Roquebert, J C Plantier, A Ganon, D Sizmann, R Babiel, J Glaubitz, M L Chaix, F Brun-Vezinet, D Descamps, C Rouzioux.   

Abstract

We evaluated the performance of the prototype Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, using prospective and archived clinical samples initially underquantitated by the Cobas AmpliPrep/Cobas TaqMan HIV-1 test. The performance of the new test was significantly improved, and the majority of the underquantitation observed with the first-version test was eliminated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20129964      PMCID: PMC2849598          DOI: 10.1128/JCM.01409-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  HIV-1 subtypes and plasma RNA quantification.

Authors:  F Damond; C Apetrei; D Descamps; F Brun-Vézinet; F Simon
Journal:  AIDS       Date:  1999-02-04       Impact factor: 4.177

2.  Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test: comparison with the Cobas Amplicor HIV-1 Monitor test (manual specimen preparation).

Authors:  Annemarie Berger; Lina Scherzed; Martin Stürmer; Wolfgang Preiser; Hans W Doerr; Holger F Rabenau
Journal:  J Clin Virol       Date:  2002-12       Impact factor: 3.168

3.  Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes.

Authors:  Marie Gueudin; Jean Christophe Plantier; Véronique Lemée; Marie Paule Schmitt; Loic Chartier; Thomas Bourlet; Annick Ruffault; Florence Damond; Muriel Vray; François Simon
Journal:  J Acquir Immune Defic Syndr       Date:  2007-04-15       Impact factor: 3.731

4.  Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.

Authors:  M Wirden; R Tubiana; F Marguet; I Leroy; A Simon; M Bonmarchand; Z Ait-Arkoub; R Murphy; A G Marcelin; C Katlama; V Calvez
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

5.  Subtype-specific problems with quantification of plasma HIV-1 RNA.

Authors:  A Alaeus; K Lidman; A Sönnerborg; J Albert
Journal:  AIDS       Date:  1997-06       Impact factor: 4.177

6.  Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Authors:  J W Mellors; A Muñoz; J V Giorgi; J B Margolick; C J Tassoni; P Gupta; L A Kingsley; J A Todd; A J Saah; R Detels; J P Phair; C R Rinaldo
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.

Authors:  Wolfram Schumacher; Edmund Frick; Mirko Kauselmann; Viola Maier-Hoyle; Reinier van der Vliet; Reiner Babiel
Journal:  J Clin Virol       Date:  2007-02-27       Impact factor: 3.168

9.  Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays.

Authors:  F Damond; B Roquebert; A Bénard; G Collin; M Miceli; P Yéni; F Brun-Vezinet; D Descamps
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

10.  Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays.

Authors:  Lesley E Scott; Lara D Noble; Jackie Moloi; Linda Erasmus; Willem D F Venter; Wendy Stevens
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

View more
  21 in total

1.  Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia.

Authors:  Gudrun Naeth; Robert Ehret; Frank Wiesmann; Patrick Braun; Heribert Knechten; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2012-06-15       Impact factor: 3.402

2.  Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patients.

Authors:  Cecile D Lahiri; Sijia Tao; Yong Jiang; Anandi N Sheth; Edward P Acosta; Vincent C Marconi; Wendy S Armstrong; Raymond F Schinazi; Aswani Vunnava; Sara Sanford; Ighovwerha Ofotokun
Journal:  AIDS       Date:  2015-06-01       Impact factor: 4.177

3.  Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany.

Authors:  Michael Chudy; Julia Kress; Jochen Halbauer; Margarethe Heiden; Markus B Funk; C Micha Nübling
Journal:  Transfus Med Hemother       Date:  2013-12-19       Impact factor: 3.747

4.  An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study.

Authors:  F Damond; A Benard; Claudia Balotta; Jürg Böni; Matthew Cotten; Vitor Duque; Bridget Ferns; Jeremy Garson; Perpetua Gomes; Fátima Gonçalves; Geoffrey Gottlieb; Bernd Kupfer; Jean Ruelle; Berta Rodes; Vicente Soriano; Mark Wainberg; Audrey Taieb; Sophie Matheron; Genevieve Chene; Francoise Brun-Vezinet
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

5.  New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load.

Authors:  Véronique Avettand-Fenoel; Florence Damond; Marie Gueudin; Sophie Matheron; Adeline Mélard; Gilles Collin; Diane Descamps; Marie-Laure Chaix; Christine Rouzioux; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

6.  Evaluation of the Aptima HIV-1 Quant Dx Assay Using Plasma and Dried Blood Spots.

Authors:  Malaya K Sahoo; Vici Varghese; Elizabeth White; Meg Winslow; David A Katzenstein; Robert W Shafer; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2016-08-17       Impact factor: 5.948

7.  Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical Trials.

Authors:  Will Garner; Kirsten White; Javier Szwarcberg; Scott McCallister; Lijie Zhong; Mike Wulfsohn
Journal:  Clin Infect Dis       Date:  2015-12-21       Impact factor: 9.079

Review 8.  Non-M variants of human immunodeficiency virus type 1.

Authors:  Thomas Mourez; François Simon; Jean-Christophe Plantier
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

9.  Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected Patients.

Authors:  Pedro Borrego; Maria Fátima Gonçalves; Perpétua Gomes; Lavínia Araújo; Inês Moranguinho; Inês Brito Figueiredo; Isabel Barahona; José Rocha; Claudino Mendonça; Maria Cesarina Cruz; Jorge Barreto; Nuno Taveira
Journal:  J Clin Microbiol       Date:  2017-05-17       Impact factor: 5.948

Review 10.  HIV transmission.

Authors:  George M Shaw; Eric Hunter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.